In her role, Jen partners with a broad set of cross-functional stakeholders to ensure that the North America business runs effectively. She drives operational support for product launches by partnering with therapeutic and functional leads to ensure best practices are employed, timelines are met, and cross-functional coordination is optimized. She also supports close integration of the US teams with the Global Brand Franchises in support of upcoming product launches.
Prior to her current role, Jen was a Principal at The Boston Consulting Group (BCG) where she spent eight years leading projects across the Healthcare sector with biotech and Biopharma companies, including work with EMD Serono starting in 2014 both at the global level and with the US business across all therapeutic areas. Jen brings a broad range of experience from her time at BCG, spanning from R&D through Commercial and with deep expertise in Medical Affairs and Market Access.
Jen holds a PhD in Biological Chemistry from the Massachusetts Institute of Technology and a Bachelor of Arts from Wheaton College in Norton, MA.
You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.
If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website.